DK2425844T3 - Autolog og allogen stromastamcellesammensætning, der stammer fra fedtvæv, til behandling af fistler - Google Patents

Autolog og allogen stromastamcellesammensætning, der stammer fra fedtvæv, til behandling af fistler

Info

Publication number
DK2425844T3
DK2425844T3 DK09844076.1T DK09844076T DK2425844T3 DK 2425844 T3 DK2425844 T3 DK 2425844T3 DK 09844076 T DK09844076 T DK 09844076T DK 2425844 T3 DK2425844 T3 DK 2425844T3
Authority
DK
Denmark
Prior art keywords
fistulas
autologous
treatment
stem cell
adipose tissue
Prior art date
Application number
DK09844076.1T
Other languages
English (en)
Inventor
Sung-Koo Lee
Mi-Hyung Kim
Original Assignee
Anterogen Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anterogen Co Ltd filed Critical Anterogen Co Ltd
Application granted granted Critical
Publication of DK2425844T3 publication Critical patent/DK2425844T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK09844076.1T 2009-04-28 2009-06-09 Autolog og allogen stromastamcellesammensætning, der stammer fra fedtvæv, til behandling af fistler DK2425844T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20090036942 2009-04-28
PCT/KR2009/003078 WO2010126194A1 (ko) 2009-04-28 2009-06-09 누공 치료를 위한 자가 및 동종의 지방 유래 스트로마 줄기세포 조성물

Publications (1)

Publication Number Publication Date
DK2425844T3 true DK2425844T3 (da) 2014-06-16

Family

ID=43032324

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09844076.1T DK2425844T3 (da) 2009-04-28 2009-06-09 Autolog og allogen stromastamcellesammensætning, der stammer fra fedtvæv, til behandling af fistler

Country Status (9)

Country Link
US (2) US20120020937A1 (da)
EP (1) EP2425844B1 (da)
JP (1) JP5647230B2 (da)
KR (2) KR101328604B1 (da)
CN (1) CN102421444B (da)
DK (1) DK2425844T3 (da)
ES (1) ES2479621T3 (da)
IL (1) IL215491A (da)
WO (1) WO2010126194A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060045872A1 (en) 2004-08-25 2006-03-02 Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco Use of adipose tissue-derived stromal stem cells in treating fistula
AU2012279995C1 (en) 2011-07-06 2019-10-24 Cell Therapy Limited Progenitor cells of mesodermal lineage
DK2744892T3 (da) * 2011-09-23 2019-04-23 Cell Ideas Pty Ltd Terapeutik, der anvender fedtceller og cellesekretioner
KR101603633B1 (ko) * 2013-06-12 2016-03-15 한국생명공학연구원 EGF 또는 bFGF를 포함하는 배지에서 배양한 지방유래 줄기세포의 증식 및 치료능력 탐지 마커 및 이의 용도
US10368852B2 (en) * 2013-06-26 2019-08-06 Strait Access Technologies Holdings (Pty) Ltd Orientation device for use in mitral valve repair
KR101667001B1 (ko) * 2013-08-12 2016-10-17 한국생명공학연구원 줄기세포 배양액에서 탐지 가능한 지방유래 줄기세포의 증식 및 치료능력 탐지용 마커 및 이의 용도
US10123870B2 (en) * 2013-09-12 2018-11-13 St. Jude Medical, Cardiology Division, Inc. Alignment of an implantable medical device
JP6173157B2 (ja) * 2013-10-02 2017-08-02 日本製薬株式会社 Ｉｌ−１７産生抑制組成物
KR101495281B1 (ko) 2014-01-10 2015-02-24 (주)안트로젠 피부 재생 또는 상처 치유를 위한 중간엽 줄기세포-하이드로겔-생분해성 또는 중간엽 줄기세포-하이드로겔-비분해성 지지체 조성물
GB201604304D0 (en) * 2016-03-14 2016-04-27 Tigenix S A U Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease
KR101926331B1 (ko) 2016-04-12 2018-12-07 (주)안트로젠 수포성 표피박리증 완화 또는 개선용 중간엽줄기세포-하이드로겔-생분해성 또는 중간엽줄기세포-하이드로겔-비분해성 지지체 조성물
CN110564688B (zh) * 2018-06-06 2022-08-26 中山大学中山眼科中心 一种无血清培养角膜缘基质干细胞并于体外诱导成球和诱导分化的方法
CA3200227A1 (en) * 2020-11-25 2022-06-02 Alexandra Sophie DE BOER Adipogenic cell compositions and methods
CN120380135A (zh) * 2022-01-27 2025-07-25 艾恩健康寿命股份有限公司 分析可溶性肿瘤坏死因子受体2(stnfr2)的方法以及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6082364A (en) * 1997-12-15 2000-07-04 Musculoskeletal Development Enterprises, Llc Pluripotential bone marrow cell line and methods of using the same
US6777231B1 (en) 1999-03-10 2004-08-17 The Regents Of The University Of California Adipose-derived stem cells and lattices
KR20050044393A (ko) * 2001-11-09 2005-05-12 아르테셀 사이언스, 인크. 지방 조직 유래된 스트로마 세포의 내분비 췌장 분화 및이의 용도
AU2003220424A1 (en) * 2002-03-19 2003-10-08 Advanced Research And Technology Transfer Adipose stromal stem cells for tissue and vascular modification
ITTO20020311A1 (it) * 2002-04-10 2003-10-10 Medestea Int Spa Procedimento per la preparazione di cellule staminali da tessuto muscolare e tessuto adiposo umano e cellule staminali ottenibili mediante t
US20060045872A1 (en) * 2004-08-25 2006-03-02 Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco Use of adipose tissue-derived stromal stem cells in treating fistula
TW200726474A (en) 2005-07-15 2007-07-16 Cognate Therapeutics Inc The immunophenotype and immunogenicity of human adipose derived cells

Also Published As

Publication number Publication date
JP2012525377A (ja) 2012-10-22
US20150376573A1 (en) 2015-12-31
IL215491A0 (en) 2011-12-29
KR20100118491A (ko) 2010-11-05
CN102421444B (zh) 2016-08-03
EP2425844A4 (en) 2012-11-28
ES2479621T3 (es) 2014-07-24
KR20120055509A (ko) 2012-05-31
HK1164144A1 (zh) 2012-09-21
EP2425844B1 (en) 2014-05-07
CN102421444A (zh) 2012-04-18
JP5647230B2 (ja) 2014-12-24
EP2425844A1 (en) 2012-03-07
US20120020937A1 (en) 2012-01-26
WO2010126194A1 (ko) 2010-11-04
IL215491A (en) 2015-06-30
KR101328604B1 (ko) 2013-11-11

Similar Documents

Publication Publication Date Title
DK2425844T3 (da) Autolog og allogen stromastamcellesammensætning, der stammer fra fedtvæv, til behandling af fistler
DK2456391T3 (da) Transplantationsmaterialer til brystkirurgiske procedurer
DK3214170T3 (da) Pluripotent stamcelle, der kan isoleres fra kropsvæv
DK2283117T3 (da) Fremgangsmåde til oprensning af pancreatiske endodermceller afledt fra humane embryoniske stamceller
WO2010120757A3 (en) Regeneration of tissue without cell transplantation
DK2620493T3 (da) Mesenkymale stamceller til behandling af CNS-sygdomme
DK3109326T3 (da) Sammensætning og fremgangsmåde til nukleinsyresyntese og amplifikation under anvendelse af rt
DK3196309T3 (da) Thraustochytrider, fedtsyresammensætninger og fremgangsmåder til fremstilling og anvendelse deraf
DK2488636T3 (da) Fremgangsmåde til oprensning af adenoviruspartikler fra kulturer med høj celledensitet
DK3795573T3 (da) Bestemte triazolopyraziner, sammensætninger deraf og fremgangsmåder til anvendelse deraf
DK2456476T3 (da) Partikelformigt vævstransplantat med komponenter af forskellig tæthed og fremgangsmåder til fremstilling og anvendelse deraf
DK2331109T3 (da) Fremgangsmåder og sammensætninger til behandling af knogledefekter med placentale cellepopulationer
DK2442734T3 (da) Anordning til endoskopisk resektion eller fjernelse af væv
DK2424972T3 (da) Kryobeskyttende midler til frysetørring af mælkesyrebakterier
DK2601971T3 (da) Sammensætning til regenerering af normalt væv fra fibrotisk væv
DK2987507T3 (da) Fremgangsmåder til behandling af degenerative knogletilstande
DK3284820T3 (da) Fremgangsmåde til behandling af pyropheophytin-holdige sammensætninger
DK3128014T3 (da) Midler og fremgangsmåder til sterilisering af biofunktionelle sammensætninger
DK3572100T3 (da) Sammensætning til stimulering af epitelcellevækst
DK2635282T3 (da) Sammensætninger til behandling af myelofibrose
DK2839004T3 (da) Fremgangsmåde til at behandle diabetes og/eller fremme overlevelse af langerhanske øer efter transplantation
DK3378930T3 (da) Scaffold til vækst af væv in vivo
DK2391225T3 (da) Fremgangsmåde til fremstilling af lactoferrin
DK2408446T3 (da) Anvendelse af farmaceutiske sammensætninger, der indeholder mesembrenon
DK2415349T3 (da) Fremgangsmåde til fremstilling af afsaltet mælk, og afsaltet mælk